Salvinorin A

Salvinorin A
Clinical data
Routes of
administration		Inhalation, sublingual, buccal
ATC code
  • none
Legal status
Legal status
  • AU: S9 (Prohibited substance)
  • BR: Class F2 (Prohibited psychotropics)[1]
  • CA: Schedule IV
  • UK: Under Psychoactive Substances Act
  • Uncontrolled (though Salvia divinorum is controlled in some parts of the world, such as in certain states in the US)
Identifiers
IUPAC name
  • methyl (2S,4aR,6aR,7R,9S,10aS,10bR)-9-(acetyloxy)-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxo-dodecahydro-1H-naphtho[2,1-c]pyran-7-carboxylate
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.215.796
Chemical and physical data
FormulaC23H28O8
Molar mass432.469 g·mol−1
3D model (JSmol)
Specific rotation[α]D = -45.3° at 22 °C/ (c = 8.530 CHCl3); [α]D = -41° at 25 °C (c = 1 in CHCl3)
Melting point238 to 240 °C (460 to 464 °F) (also reported 242–244 °C)[2]
Boiling point760.2 °C (1,400.4 °F)
Solubility in water25.07 mg/L at 25 °C (water, est) mg/mL (20 °C)
SMILES
  • O=C(OC)[C@H]2[C@@]3(CC[C@H]4C(=O)O[C@H](c1ccoc1)C[C@@]4([C@H]3C(=O)[C@@H](OC(=O)C)C2)C)C
InChI
  • InChI=1S/C23H28O8/c1-12(24)30-16-9-15(20(26)28-4)22(2)7-5-14-21(27)31-17(13-6-8-29-11-13)10-23(14,3)19(22)18(16)25/h6,8,11,14-17,19H,5,7,9-10H2,1-4H3/t14-,15-,16-,17-,19-,22-,23-/m0/s1 Y
  • Key:OBSYBRPAKCASQB-AGQYDFLVSA-N Y
 NY (what is this?)  (verify)

Salvinorin A is the main active psychotropic molecule in Salvia divinorum. Salvinorin A is considered an atypical dissociative hallucinogen.[3][4][5]

It is structurally distinct from other naturally occurring hallucinogens (such as DMT, psilocybin, and mescaline) because it contains no nitrogen atoms; hence, it is not an alkaloid (and cannot be rendered as a salt), but rather is a terpenoid.[4] It also differs in subjective experience, compared to other hallucinogens, and has been described as having strong dissociative effects.[5]

Salvinorin A can produce psychoactive experiences in humans with a typical duration of action being several minutes to an hour or so, depending on the method of ingestion.[6]

Salvinorin A is found with several other structurally related salvinorins. Salvinorin is a trans-neoclerodane diterpenoid. It acts as a kappa opioid receptor agonist and is the first known compound acting on this receptor that is not an alkaloid.[6]

  1. ^ Anvisa (2023-07-24). "RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-07-25). Archived from the original on 2023-08-27. Retrieved 2023-08-27.
  2. ^ salvinorin A, PubChem, retrieved 2012-11-23
  3. ^ Doss MK, May DG, Johnson, MW (2020). "The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human Brain". Scientific Reports. 10 16392. doi:10.1038/s41598-020-73216-8. PMC 7532139.
  4. ^ a b Butelman ER, Kreek MJ (2015). "Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders". Frontiers in Pharmacology. 6: 190. doi:10.3389/fphar.2015.00190. PMC 4561799. PMID 26441647.
  5. ^ a b MacLean KA, Johnson MW, Reissig CJ, Prisinzano TE, Griffiths RR (March 2013). "Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects". Psychopharmacology. 226 (2): 381–392. doi:10.1007/s00213-012-2912-9. PMC 3581702. PMID 23135605.
  6. ^ a b Cite error: The named reference Roth2002 was invoked but never defined (see the help page).
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.